Waystar (NASDAQ:WAY – Get Free Report) is expected to be posting its Q1 2026 results after the market closes on Wednesday, April 29th. Analysts expect Waystar to post earnings of $0.39 per share and revenue of $311.7220 million for the quarter. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. Investors may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Wednesday, April 29, 2026 at 4:30 PM ET.
Waystar (NASDAQ:WAY – Get Free Report) last announced its quarterly earnings data on Tuesday, February 17th. The company reported $0.36 EPS for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.03). The company had revenue of $303.54 million for the quarter, compared to analysts’ expectations of $294.72 million. Waystar had a return on equity of 6.86% and a net margin of 10.20%.The business’s quarterly revenue was up 24.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.29 EPS. On average, analysts expect Waystar to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Waystar Stock Performance
NASDAQ WAY opened at $25.42 on Monday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.41 and a current ratio of 1.41. The stock’s fifty day moving average is $24.57 and its two-hundred day moving average is $29.99. The firm has a market capitalization of $4.87 billion, a P/E ratio of 41.67, a price-to-earnings-growth ratio of 0.98 and a beta of 0.87. Waystar has a fifty-two week low of $20.93 and a fifty-two week high of $42.55.
Hedge Funds Weigh In On Waystar
Analyst Ratings Changes
Several brokerages have recently weighed in on WAY. Leerink Partners initiated coverage on shares of Waystar in a research report on Monday, February 2nd. They set an “outperform” rating and a $43.00 price target on the stock. Raymond James Financial restated a “strong-buy” rating and set a $35.00 price objective on shares of Waystar in a research report on Thursday, March 5th. Needham & Company LLC reduced their target price on shares of Waystar from $46.00 to $33.00 and set a “buy” rating on the stock in a research note on Tuesday, February 17th. Truist Financial dropped their price target on shares of Waystar from $51.00 to $38.00 and set a “buy” rating for the company in a research note on Wednesday, February 18th. Finally, BMO Capital Markets cut their price target on shares of Waystar from $47.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, February 18th. Three equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $36.65.
Waystar Company Profile
Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
Featured Articles
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
